Captor Therapeutics Spolka Akcyjna
WSE: CTX.WA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michal Walczak
- Employees
- 105
- Headquarters
- Wroclaw, Poland
- IPO year
- 2021
- Market cap
- PLN 435.2M
- Website
- https://www.captortherapeutics.com
Loading CTX…
Loading profile data…Frequently asked questions about CTX
What does Captor Therapeutics Spolka Akcyjna (CTX.WA) do?
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five...
Where does CTX.WA trade?
Captor Therapeutics Spolka Akcyjna (CTX.WA) trades on the Warsaw Stock Exchange.
What sector is CTX.WA in?
Captor Therapeutics Spolka Akcyjna (CTX.WA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Captor Therapeutics Spolka Akcyjna?
Michal Walczak is the chief executive officer of Captor Therapeutics Spolka Akcyjna (CTX.WA).
Where is Captor Therapeutics Spolka Akcyjna headquartered?
Captor Therapeutics Spolka Akcyjna is headquartered in Poland.
Does CTX.WA pay a dividend?
Captor Therapeutics Spolka Akcyjna (CTX.WA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CTX.WA go public?
Captor Therapeutics Spolka Akcyjna (CTX.WA) completed its initial public offering in 2021.